| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/23/2009 | CN101537077A Chinese medicinal mixed tincture |
| 09/23/2009 | CN101537073A Chinese traditional medicine composition for curing lumbar muscle strain and preparation method thereof |
| 09/23/2009 | CN101537069A Chinese medicinal preparation for treating erythromelalgia |
| 09/23/2009 | CN101537038A Pharmaceutical composition for preventing and curing children cold and preparation method thereof |
| 09/23/2009 | CN101537005A Codein and chlorphenamine compound sustained release capsules |
| 09/23/2009 | CN101537003A Application of 7,3'-dimethoxy hesperetin in preparation of anti-inflammatory immune medicaments |
| 09/23/2009 | CN101536997A Application of ginseng alkynol in pharmacy |
| 09/23/2009 | CN101536994A Method for preparing hybrid nanofiber membrane capable of loading drug |
| 09/23/2009 | CN101536981A Clonidine hydrochloride multivesicular liposome and preparation method thereof |
| 09/23/2009 | CN101536812A Health-care cigarette and manufacturing method thereof |
| 09/23/2009 | CN100543016C Intermediate compound of 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives |
| 09/23/2009 | CN100542560C Chinese medicine for treating chronic pelvic inflammation and its preparing process |
| 09/22/2009 | US7592455 potent and selective inhibitors of p38 kinase, especially p38 alpha , p38 beta and p38 beta 2; immune or inflammatory disorders; Ethyl 3-(benzylamino)-6-oxo-7-phenyl-6,7-dihydrothieno[2,3-b]pyridine-2-carboxylate |
| 09/22/2009 | US7592450 used to inhibit proliferative conditions, such as cancer and psoriasis, with improved bioavailability and stability |
| 09/22/2009 | US7592437 Genes involved in intestinal inflammatory diseases and use thereof |
| 09/22/2009 | US7592430 Monoclonal antibody specific to macrophage colony stimulating factor (M-CSF) for use in treatment and prevention of infection, inflammation, nervous system, respiratory system, bone and skin disorders |
| 09/22/2009 | US7592329 containing an anti-inflammatory and anti-allergic compound of the androstane series |
| 09/22/2009 | US7592007 Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies |
| 09/22/2009 | US7592005 Multiple myeloma; targeting antibody conjugated with a radionuclide or other cytotoxic substance |
| 09/22/2009 | US7591949 Method for the improvement of transport across adaptable semi-permeable barriers |
| 09/22/2009 | CA2503767C Pyridopyrrolizine and pyridoindolizine derivatives |
| 09/22/2009 | CA2450833C Compositions comprising thylakoids useful in the modulation of the inflammation process |
| 09/22/2009 | CA2426349C Over-coated chewing gum formulations including tableted center |
| 09/22/2009 | CA2399451C Tyrosine derivatives with anti-leukotriene activity |
| 09/22/2009 | CA2397554C Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents |
| 09/22/2009 | CA2360894C (1-phenacyl-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same |
| 09/22/2009 | CA2353727C Use of amtolmetin guacyl for the production of anti-inflammatory drugs for intestinal inflammations |
| 09/19/2009 | CA2717166A1 Methods of modulating t cell-dependent immune responses |
| 09/17/2009 | WO2009114650A1 Methods and compositions for treating inflammation and inflammation-related pathologies |
| 09/17/2009 | WO2009114139A2 Methods, compositions, and kits for treating pain and pruritis |
| 09/17/2009 | WO2009114097A2 Method of modulating t cell-dependent immune responses |
| 09/17/2009 | WO2009114088A2 Fullerene therapies for inflammation |
| 09/17/2009 | WO2009113910A1 Antiinflammatory and antiallergic gel |
| 09/17/2009 | WO2009113423A1 Bicyclic pyrrole compound |
| 09/17/2009 | WO2009113320A1 Mmp inhibitor |
| 09/17/2009 | WO2009112826A1 Furo [3, 2-b] pyrr0l-3-0nes as cathepsin s inhibitors |
| 09/17/2009 | WO2009112679A1 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 09/17/2009 | WO2009112678A2 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 09/17/2009 | WO2009112677A2 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 09/17/2009 | WO2009112674A2 Compounds for use in the treatment of neuropathic pain |
| 09/17/2009 | WO2009112651A1 Imidazo[1,2-a]pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics |
| 09/17/2009 | WO2009112473A1 Novel compounds |
| 09/17/2009 | WO2009111948A1 The salts of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)piperidine-2,6-dione or its derivatives, their polymorphs, preparation methods and uses thereof |
| 09/17/2009 | WO2003007876A3 N-fatty acid-amino acid conjugates and therapeutic uses |
| 09/17/2009 | US20090234000 Triptolide Analogs for the Treatment of Autoimmune and Inflammatory Disorders |
| 09/17/2009 | US20090233970 Combined nsaid and acid blocker formulation and method |
| 09/17/2009 | US20090233969 Biaryl substituted nitrogen containing heterocycle inhibitors of lta4h for treating inflammation |
| 09/17/2009 | US20090233909 Sulfonamide compounds as cysteine protease inhibitors |
| 09/17/2009 | US20090233878 Novel adenosine a3 receptor agonists |
| 09/17/2009 | US20090233865 Nutritional Compositions |
| 09/17/2009 | US20090233855 Compounds and methods for modulating activation of nf-kb |
| 09/17/2009 | US20090233311 receptor binding assay; analysis and determining the level of procalcitonin in blood wherein an increased level of procalcitonin compared to healthy individuals is indicative of sepsis |
| 09/17/2009 | US20090232809 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/17/2009 | US20090232803 Antibodies to human il-1beta |
| 09/17/2009 | US20090232736 Dual specificity antibodies and methods of making and using |
| 09/17/2009 | CA2732764A1 Methods and compositions for treating inflammation and inflammation-related pathologies |
| 09/17/2009 | CA2718252A1 Bicyclic pyrrole compound |
| 09/17/2009 | CA2717495A1 Fullerene therapies for inflammation |
| 09/17/2009 | CA2717042A1 Methods, compositions, and kits for treating pain and pruritis |
| 09/17/2009 | CA2715110A1 Compounds for use in the treatment of neuropathic pain |
| 09/17/2009 | CA2712914A1 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 09/17/2009 | CA2712629A1 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 09/17/2009 | CA2712609A1 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 09/17/2009 | CA2710797A1 Imidazo[1,2-.alpha.]pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics |
| 09/16/2009 | EP2100893A1 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists |
| 09/16/2009 | EP2100888A2 Process for the preparation of duloxetine hydrochloride |
| 09/16/2009 | EP2100876A2 New compounds for the inhibition of rotamases and use thereof |
| 09/16/2009 | EP2100617A1 Methods of modulating CD200 receptors |
| 09/16/2009 | EP2099805A2 Novel aminothienopyridinone derivatives processes for preparing them and pharmaceutical compositions thereof |
| 09/16/2009 | EP2099803A1 Heterobicyclic matrix metalloprotease inhibitors |
| 09/16/2009 | EP2099798A1 Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases |
| 09/16/2009 | EP2099796A1 Aza-indolyl compounds and methods of use |
| 09/16/2009 | EP2099792A1 Heterotricyclic metalloprotease inhibitors |
| 09/16/2009 | EP2099779A1 Crystalline forms of aryl-substituted pyrazole-amide compounds |
| 09/16/2009 | EP2099767A1 Modulators of glucocorticoid receptor, ap-1, and/or nf- b activity and use thereof |
| 09/16/2009 | EP2099464A2 Local administration of gallium compositions to treat pain |
| 09/16/2009 | EP2099446A1 Method of treatment for inflammatory bowel disease |
| 09/16/2009 | EP1523471B1 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 09/16/2009 | EP1517919B9 Marked peptides having affinity for a phospholipid and uses |
| 09/16/2009 | EP1487807B1 Cyano-pyrrolidines as DPP-IV inhibitors |
| 09/16/2009 | EP1478656B1 Oligonucleotide compositions with enhanced efficiency |
| 09/16/2009 | EP1414825B9 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 09/16/2009 | EP1363629B1 Kappa opioid receptor ligands |
| 09/16/2009 | EP1283834B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/16/2009 | EP1254238B1 Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 09/16/2009 | EP1192125B9 Mono-substituted 3-propyl gamma-aminobutyric acids |
| 09/16/2009 | EP1126878B1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 09/16/2009 | CN101534823A Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |
| 09/16/2009 | CN101531721A Industrial preparation method for triterpenoid saponin monomer |
| 09/16/2009 | CN101531704A Peptide-based compounds |
| 09/16/2009 | CN101531653A Salts of 3-(4-amino-1-oxo-1,3-dihydro-iso-indol-2-yl)piperdine-2,6-dione and derivatives thereof, polymorph of the salts, preparation and application thereof |
| 09/16/2009 | CN101531649A Method for preparing andrographolide derivatives and preparation thereof |
| 09/16/2009 | CN101531611A Method for preparing aminoprofen with high purity |
| 09/16/2009 | CN101531607A Improved method for preparing aceclofenac |
| 09/16/2009 | CN101531590A Ginkgoic acid preparation method using macroporous adsorption resin |
| 09/16/2009 | CN101530607A Method for extracting gingerol type material from ginger with high efficiency |
| 09/16/2009 | CN101530588A External tincture |
| 09/16/2009 | CN101530587A Medicament for treating abasia and rheumatism |
| 09/16/2009 | CN101530583A Composition and preparation method of thin paste for treating pain and numbness |
| 09/16/2009 | CN101530568A Paralysis-expelling pain-relieving capsule |